BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26929045)

  • 1. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
    Zdenkowski N; Butow P; Mann GB; Fewster S; Beckmore C; Isaacs R; Douglas C; Boyle FM
    Intern Med J; 2016 Jun; 46(6):677-83. PubMed ID: 26929045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer.
    Zdenkowski N; Butow P; Spillane A; Douglas C; Snook K; Jones M; Oldmeadow C; Fewster S; Beckmore C; Boyle FM
    Breast; 2019 Aug; 46():25-31. PubMed ID: 31059987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.
    Burgués O; López-García MÁ; Pérez-Míes B; Santiago P; Vieites B; García JF; Peg V
    Clin Transl Oncol; 2018 Mar; 20(3):382-391. PubMed ID: 28795336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists.
    Zdenkowski N; Butow P; Mann B; Fewster S; Douglas C; Boyle FM
    ANZ J Surg; 2015 Nov; 85(11):797-8. PubMed ID: 26798858
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Zdenkowski N; Butow P; Spillane A; Douglas C; Snook K; Jones M; Oldmeadow C; Fewster S; Beckmore C; Boyle FM;
    J Natl Compr Canc Netw; 2018 Apr; 16(4):378-385. PubMed ID: 29632057
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy.
    Nguyen K; Mackenzie P; Allen A; Dreosti M; Morgia M; Zissiadis Y; Lamoury G; Windsor A
    J Med Imaging Radiat Oncol; 2017 Aug; 61(4):508-516. PubMed ID: 27987274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's Experiences with Deciding on Neoadjuvant Systemic Therapy for Operable Breast Cancer: A Qualitative Study.
    Herrmann A; Hall A; Zdenkowski N
    Asia Pac J Oncol Nurs; 2018; 5(1):68-76. PubMed ID: 29379837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
    Pfob A; Cai L; Schneeweiss A; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten MM; Sidey-Gibbons C; Wallwiener M; Golatta M; Heil J
    Ann Surg Oncol; 2024 Feb; 31(2):957-965. PubMed ID: 37947974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000.
    Chong CC; Austen L; Kneebone A; Lalak A; Jalaludin B
    BJU Int; 2006 May; 97(5):975-80. PubMed ID: 16542341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer.
    Herrmann A; Boyle F; Butow P; Hall AE; Zdenkowski N
    Health Sci Rep; 2018 Jan; 1(1):e13. PubMed ID: 30623032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The underused potential of breast conserving therapy after neoadjuvant system treatment - Causes and solutions.
    Pfob A; Dubsky P
    Breast; 2023 Feb; 67():110-115. PubMed ID: 36669994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis.
    Brown L; Naffouje SA; Sam C; Laronga C; Catherine Lee M
    Breast Cancer Res Treat; 2022 Dec; 196(3):441-451. PubMed ID: 36207620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
    Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A
    Breast J; 2019 Jan; 25(1):34-40. PubMed ID: 30525267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.
    Clough KB; Acosta-Marín V; Nos C; Alran S; Rouanet P; Garbay JR; Giard S; Verhaeghe JL; Houvenaeghel G; Flipo B; Dauplat J; Dorangeon PH; Classe JM; Rouzier R; Bonnier P
    Ann Surg Oncol; 2015 Oct; 22(11):3504-11. PubMed ID: 25665949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers.
    Knelson LP; Cukras AR; Savoie J; Agarwal A; Guo H; Hu J; Fell G; Lederman R; Hughes ME; Winer EP; Lin NU; Tolaney SM
    Clin Breast Cancer; 2020 Oct; 20(5):395-401.e3. PubMed ID: 32605813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
    Braga S
    Methods Mol Biol; 2016; 1395():251-80. PubMed ID: 26910079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.
    Buchholz TA; Hunt KK; Whitman GJ; Sahin AA; Hortobagyi GN
    Cancer; 2003 Sep; 98(6):1150-60. PubMed ID: 12973838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
    Read RL; Flitcroft K; Snook KL; Boyle FM; Spillane AJ
    ANZ J Surg; 2015 May; 85(5):315-20. PubMed ID: 25612239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists.
    Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM
    Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.